James F Sumowski1, Maria A Rocca2, Victoria M Leavitt2, Alessandro Meani2, Sarlota Mesaros2, Jelena Drulovic2, Paolo Preziosa2, Christian G Habeck2, Massimo Filippi2. 1. From the Department of Neurology (J.F.S.), Icahn School of Medicine at Mount Sinai, New York, NY; Neuroimaging Research Unit, Division of Neuroscience (M.A.R., A.M., P.P., M.F.), and Department of Neurology (M.A.R., M.F.), San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy; Department of Neurology (V.M.L., C.G.H.), Columbia University Medical Center, New York, NY; and Clinic of Neurology (S.M., J.D.), Faculty of Medicine, University of Belgrade, Serbia. james.sumowski@mssm.edu. 2. From the Department of Neurology (J.F.S.), Icahn School of Medicine at Mount Sinai, New York, NY; Neuroimaging Research Unit, Division of Neuroscience (M.A.R., A.M., P.P., M.F.), and Department of Neurology (M.A.R., M.F.), San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy; Department of Neurology (V.M.L., C.G.H.), Columbia University Medical Center, New York, NY; and Clinic of Neurology (S.M., J.D.), Faculty of Medicine, University of Belgrade, Serbia.
Abstract
OBJECTIVE: The brain reserve hypothesis links larger maximal lifetime brain growth (MLBG, estimated with intracranial volume [ICV]) with lower risk for cognitive decline/dementia. We examined whether larger MLBG is also linked to less physical disability progression over 5 years in a prospective sample of treatment-naive patients with multiple sclerosis (MS). METHODS: Physical disability was measured with the Expanded Disability Status Scale (EDSS) at baseline and 5-year follow-up in 52 treatment-naive Serbian patients with MS. MRI measured disease burden (cerebral atrophy, T2 lesion volume) and MLBG: a genetically determined, premorbid (established during adolescence, stable thereafter) patient characteristic estimated with ICV (adjusted for sex). Logistic regression tested whether MLBG (smaller vs larger) predicts disability progression (stable vs worsened) independently of disease burden. RESULTS: Disability progression was observed in 29 (55.8%) patients. Larger MLBG predicted lower risk for progression (odds ratio 0.13, 95% confidence interval 0.02-0.78), independently of disease burden. We also calculated absolute change in EDSS scores, and observed that patients with smaller MLBG showed worse EDSS change (0.91 ± 0.71) than patients with larger MLBG (0.42 ± 0.87). CONCLUSIONS: Larger MLBG was linked to lower risk for disability progression in patients with MS over 5 years, which is the first extension of the brain reserve hypothesis to physical disability. MLBG (ICV) represents a clinically available metric that may help gauge risk for future disability in patients with MS, which may advance the science and practice of early intervention. Potential avenues for future research are discussed.
OBJECTIVE: The brain reserve hypothesis links larger maximal lifetime brain growth (MLBG, estimated with intracranial volume [ICV]) with lower risk for cognitive decline/dementia. We examined whether larger MLBG is also linked to less physical disability progression over 5 years in a prospective sample of treatment-naive patients with multiple sclerosis (MS). METHODS: Physical disability was measured with the Expanded Disability Status Scale (EDSS) at baseline and 5-year follow-up in 52 treatment-naive Serbian patients with MS. MRI measured disease burden (cerebral atrophy, T2 lesion volume) and MLBG: a genetically determined, premorbid (established during adolescence, stable thereafter) patient characteristic estimated with ICV (adjusted for sex). Logistic regression tested whether MLBG (smaller vs larger) predicts disability progression (stable vs worsened) independently of disease burden. RESULTS: Disability progression was observed in 29 (55.8%) patients. Larger MLBG predicted lower risk for progression (odds ratio 0.13, 95% confidence interval 0.02-0.78), independently of disease burden. We also calculated absolute change in EDSS scores, and observed that patients with smaller MLBG showed worse EDSS change (0.91 ± 0.71) than patients with larger MLBG (0.42 ± 0.87). CONCLUSIONS: Larger MLBG was linked to lower risk for disability progression in patients with MS over 5 years, which is the first extension of the brain reserve hypothesis to physical disability. MLBG (ICV) represents a clinically available metric that may help gauge risk for future disability in patients with MS, which may advance the science and practice of early intervention. Potential avenues for future research are discussed.
Authors: E Courchesne; H J Chisum; J Townsend; A Cowles; J Covington; B Egaas; M Harwood; S Hinds; G A Press Journal: Radiology Date: 2000-09 Impact factor: 11.105
Authors: Giancarlo Comi; Douglas Jeffery; Ludwig Kappos; Xavier Montalban; Alexey Boyko; Maria A Rocca; Massimo Filippi Journal: N Engl J Med Date: 2012-03-15 Impact factor: 91.245
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Randy L Buckner; Denise Head; Jamie Parker; Anthony F Fotenos; Daniel Marcus; John C Morris; Abraham Z Snyder Journal: Neuroimage Date: 2004-10 Impact factor: 6.556
Authors: James F Sumowski; Maria A Rocca; Victoria M Leavitt; Jelena Dackovic; Sarlota Mesaros; Jelena Drulovic; John DeLuca; Massimo Filippi Journal: Neurology Date: 2014-04-18 Impact factor: 9.910
Authors: M Arfan Ikram; Myriam Fornage; Albert V Smith; Sudha Seshadri; Reinhold Schmidt; Stéphanie Debette; Henri A Vrooman; Sigurdur Sigurdsson; Stefan Ropele; H Rob Taal; Dennis O Mook-Kanamori; Laura H Coker; W T Longstreth; Wiro J Niessen; Anita L DeStefano; Alexa Beiser; Alex P Zijdenbos; Maksim Struchalin; Clifford R Jack; Fernando Rivadeneira; Andre G Uitterlinden; David S Knopman; Anna-Liisa Hartikainen; Craig E Pennell; Elisabeth Thiering; Eric A P Steegers; Hakon Hakonarson; Joachim Heinrich; Lyle J Palmer; Marjo-Riitta Jarvelin; Mark I McCarthy; Struan F A Grant; Beate St Pourcain; Nicholas J Timpson; George Davey Smith; Ulla Sovio; Mike A Nalls; Rhoda Au; Albert Hofman; Haukur Gudnason; Aad van der Lugt; Tamara B Harris; William M Meeks; Meike W Vernooij; Mark A van Buchem; Diane Catellier; Vincent W V Jaddoe; Vilmundur Gudnason; B Gwen Windham; Philip A Wolf; Cornelia M van Duijn; Thomas H Mosley; Helena Schmidt; Lenore J Launer; Monique M B Breteler; Charles DeCarli Journal: Nat Genet Date: 2012-04-15 Impact factor: 38.330
Authors: Sylvia Klineova; Rachel Brandstadter; Michelle T Fabian; Ilana Katz Sand; Stephen Krieger; Victoria M Leavitt; Christina Lewis; Claire S Riley; Fred Lublin; Aaron E Miller; James F Sumowski Journal: Mult Scler Date: 2019-06-07 Impact factor: 6.312
Authors: Gloria Castellazzi; Laetitia Debernard; Tracy R Melzer; John C Dalrymple-Alford; Egidio D'Angelo; David H Miller; Claudia A M Gandini Wheeler-Kingshott; Deborah F Mason Journal: Front Neurol Date: 2018-08-20 Impact factor: 4.003